Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001999371-25-018393
Filing Date
2025-11-21
Accepted
2025-11-21 16:48:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT tnxp-424b5_112125.htm 424B5 5477
2 GRAPHIC tnxp-424b5_001.jpg GRAPHIC 21112
  Complete submission text file 0001999371-25-018393.txt   35816
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282270 | Film No.: 251508700
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)